Sign in
Taking people in United StatesPhase 4

The Options 2 Study

Key facts

Who runs it
University of Wisconsin, Madison
Where
Madison, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
300 people, planned
Started
21 May 2025
Expected to end
30 Jul 2029
Type of study
Interventional, 4 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Nicotine Pouches
  • Mini Nicotine lozenges
Record updated
22 June 2026

Who can take part

Age
21 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • ≥ 21 years old (i.e., able to legally purchase tobacco products)
  • able to read and communicate in English
  • no plans to quit smoking in the next 30 days
  • willing to stop using nicotine replacement or varenicline
  • willing to stop using bupropion (i.e., Wellbutrin, Zyban) if they are currently using it only for smoking cessation
  • smoking ≥ 5 cigarettes per day for the past 6 months
  • exhaled carbon monoxide ≥ 6 ppm
  • no nicotine pouch or smokeless tobacco (including snus) use within the last 6 months

Who cannot take part

  • currently taking bupropion for non-smoking cessation reasons (e.g., Wellbutrin for depression)
  • currently in treatment for psychosis or bipolar disorder
  • currently pregnant or breastfeeding

This trial is currently available in United States.

  • University of WisconsinMadison, United StatesContact: Megan Piper, PhDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to investigate how well nicotine pouches and nicotine mini lozenges serve as substitutes for cigarettes when people try to switch from smoking to using these alternate nicotine products.

Read full original descriptionShow less

Participants will:

* Use nicotine pouches, nicotine mini lozenges, or no study product for a week and then try not to smoke for 3 weeks. * Have 6 in-person research visits and 1 follow-up call * Complete questionnaires at each study contact and use a smartphone app to record smoking and study product use

The 4 groups in the trial

  • 3mg Nicotine PouchesTreatment being tested

    Participants will use 3mg nicotine pouches

    Treatment: Nicotine Pouches

  • 6mg Nicotine PouchesTreatment being tested

    Participants will use 6mg nicotine pouches

    Treatment: Nicotine Pouches

  • Nicotine Mini LozengesTreatment being tested

    Participants will use mini lozenges with dosing based on time to first cigarette (2mg or 4mg)

    Treatment: Mini Nicotine lozenges

  • No Study ProductNo study treatment, for comparison

    Participants randomized to this arm will use a mint candy during two different 30-minute laboratory sessions only.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Comparative Effectiveness Trial of Nicotine Pouches for Cigarette Substitution: A Question of Public Health
Record updated
22 June 2026